SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000895345-24-000124
Filing Date
2024-04-16
Accepted
2024-04-16 17:16:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 ff3271547_13da6-aileron.htm SC 13D/A 50190
  Complete submission text file 0000895345-24-000124.txt   51665
Mailing Address C/O SATTER INVESTMENT MANAGEMENT, LLC 676 NORTH MICHIGAN AVENUE, SUITE 4000 CHICAGO IL 60611
Business Address
Satter Muneer A (Filed by) CIK: 0001315797 (see all company filings)

Type: SC 13D/A

Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Aileron Therapeutics, Inc. (Subject) CIK: 0001420565 (see all company filings)

IRS No.: 134196017 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90032 | Film No.: 24848696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)